Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
Trial · NCT00957372
Participant flow52
How many started, completed or left each group, period by period.
1 to 20 of 52
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| PART I | STARTED | ESL 1200mg Daily | 80 | |
| PART I | STARTED | ESL 800mg Daily | 85 | |
| PART I | STARTED | Placebo | 88 | |
| PART I | STARTED | Open-label Extension (Part II) | 0 | |
| PART I | Safety Population | ESL 1200mg Daily | 80 | |
| PART I | Safety Population | ESL 800mg Daily | 85 | |
| PART I | Safety Population | Placebo | 87 | |
| PART I | Safety Population | Open-label Extension (Part II) | 0 | |
| PART I | Intention-to-Treat Population | ESL 1200mg Daily | 77 | |
| PART I | Intention-to-Treat Population | ESL 800mg Daily | 84 | |
| PART I | Intention-to-Treat Population | Placebo | 84 | |
| PART I | Intention-to-Treat Population | Open-label Extension (Part II) | 0 | |
| PART I | Per-Protocol Population | ESL 1200mg Daily | 35 | |
| PART I | Per-Protocol Population | ESL 800mg Daily | 47 | |
| PART I | Per-Protocol Population | Placebo | 51 | |
| PART I | Per-Protocol Population | Open-label Extension (Part II) | 0 | |
| PART I | Randomized But Not Treated | ESL 1200mg Daily | 0 | |
| PART I | Randomized But Not Treated | ESL 800mg Daily | 0 | |
| PART I | Randomized But Not Treated | Placebo | 1 | |
| PART I | Randomized But Not Treated | Open-label Extension (Part II) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00957372/flow